Celltrion announced that they received the final analysis of additional clinical results of Remsima from Contract Research Organization for its applying for U.S. approval

Published: 2014-07-23 09:17:26

Updated: 2014-07-23 09:17:49

On July 21, Celltrion announced that they received the final analysis of additional clinical results of Remsima from Contract Research Organization for its applying for U.S. approval.

Celltrion plans to apply for sale approval of Remsima to U.S. Food and Drug Administration soon on the basis of the analysis report and data of global clinical trials.

According to the official notice, this addi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.